Age is the leading factor in influenza vaccine selection, and vaccination remains effective well beyond the ideal September-to-October window.
|Articles|October 5, 2021
Pharmacy Clinical Pearl of the Day: Cold Symptoms vs Flu Symptoms
Author(s)Saro Arakelians, PharmD
With the arrival of flu and cold season, note the differences between symptoms for both illnesses.
Advertisement
Clinical Pearl of the Day: Cold vs Flu
Insight:
Cold symptoms
- Fever is rare
- Aches and pain are slight
- Symptoms are gradual
- Sneezing is common
- Stuffy nose is common
- Headaches are rare
- Fatigue and weakness sometimes
- Sore throat common
Flu symptoms
- Fever and chills are common
- Aches and pains are usual
- Symptoms are abrupt
- Sneezing occurs sometimes
- Stuffy nose occurs sometimes
- Headaches are common
- Fatigue and weakness are typical
- Sore throat occurs sometimes
Sources:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
SubscribeAdvertisement
Related to this article
Pharmacists can help overcome influenza vaccine hesitancy by correcting common misconceptions, routinely asking every patient about vaccination, and leveraging their standing as trusted health care professionals.
Growing evidence points to gallstones and cholecystitis as an underrecognized risk of GLP-1 RA therapy—pharmacists are well positioned to catch it early.
A suspected plague death in Russia has renewed attention on the rare infection. Here's how to spot pneumonic plague and which antibiotics the CDC recommends.
A meta-analysis of 27 trials found 15% lower cardiovascular (CV) event risk per 10-mm Hg SBP reduction, with eGFR declines but no rise in kidney failure.
As earning years peak, so do spending and responsibility—here’s where midcareer pharmacists should focus their financial decision-making.
In the phase 2 ZUPREME 1 trial, the once-weekly amylin analog was well tolerated, with nausea mostly mild and limited to dose escalation.
Post hoc STEP UP data at EASD 2026 show liver fat fell from 8.8% to 3.1% at 72 weeks in a 55-person MRI subgroup, though no placebo comparison was reported.
Advertisement
Advertisement